SWOT Analysis for Omaxe Ltd.

Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 2 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter

Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of capital to generate profits - RoCE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Revenue and Profit
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
MACD crossed below zero line previous end of day
High promoter stock pledges
Top Losers
Declining profitability: Falling ROCE

Rising Delivery Percentage Compared to Prev Day
Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Omaxe Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats